Talipexole variations as novel bitopic dopamine D 2 and D 3 receptor ligands

2019 | journal article

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Talipexole variations as novel bitopic dopamine D 2 and D 3 receptor ligands​
Stank, L.; Frank, A.; Hagenow, S. & Stark, H. ​ (2019) 
MedChemComm10(11) pp. 1926​-1929​.​ DOI: https://doi.org/10.1039/C9MD00379G 

Documents & Media

License

Usage license

Details

Authors
Stank, Lars; Frank, Annika; Hagenow, Stefanie; Stark, Holger 
Abstract
We linked 5,6,7,8-tetrahydro-4 H -thiazoloazepine scaffolds with phenylpiperazine pharmacophores to generate bitopic dopamine receptor ligands.
We linked 2-aminothiazoloazepane scaffolds with phenylpiperazine pharmacophores to generate bitopic dopamine receptor ligands. Highest D 2 R/D 3 R binding affinities up to p K i values of 7.74 were observed for compounds containing a 1-(2,3-dichlorophenyl)piperazinoyl moiety, maintaining affinity with deaminated 5,6,7,8-tetrahydro-4 H -thiazoloazepine derivatives.
We linked 5,6,7,8-tetrahydro-4 H -thiazoloazepine scaffolds with phenylpiperazine pharmacophores to generate bitopic dopamine receptor ligands.
We linked 2-aminothiazoloazepane scaffolds with phenylpiperazine pharmacophores to generate bitopic dopamine receptor ligands. Highest D 2 R/D 3 R binding affinities up to p K i values of 7.74 were observed for compounds containing a 1-(2,3-dichlorophenyl)piperazinoyl moiety, maintaining affinity with deaminated 5,6,7,8-tetrahydro-4 H -thiazoloazepine derivatives.
Issue Date
2019
Journal
MedChemComm 
ISSN
2040-2503
eISSN
2040-2511
Language
English

Reference

Citations


Social Media